Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Verna

Showing results (151-160 of 261) with videos related to

Pageof 27
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 4, 2018
Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapyChristine Chan, Thomas Schiano, Eliana Agudelo, et al.
Transplantation|January 26, 2018
Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in ChildrenEric M Przybyszewski, Elizabeth C Verna, Steven J Lobritto, et al.
Transplantation|September 12, 2014
Hepatitis C genotype influences post-liver transplant outcomesIsabel Campos-Varela, Jennifer C Lai, Elizabeth C Verna, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 25, 2012
Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort studyJennifer C Lai, Jacqueline G O'Leary, James F Trotter, et al.
Archives of Pathology & Laboratory Medicine|April 18, 2020
COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver TransplantationStephen M Lagana, Simona De Michele, Michael J Lee, et al.
Annals of Surgery|September 10, 2016
Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the StoryKarim J Halazun, Marc Najjar, Rita M Abdelmessih, et al.
Clinical and Translational Gastroenterology|April 3, 2019
Elbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT StudyIra M Jacobson, Fred Poordad, Roberto Firpi-Morell, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 20, 2020
Analysis of patients attitude to undergo urgent endoscopic procedures during COVID-19 outbreak in ItalyE Armellini, A Repici, C Alvisi, et al.
Digestive Diseases and Sciences|July 22, 2021
Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with CirrhosisGiuseppe Cullaro, Jessica B Rubin, Brett E Fortune, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 17, 2012
Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody-positive donorsMatthew S Chang, Sonja K Olsen, Elsa M Pichardo, et al.
Pageof 27

Showing results (151-160 of 261) with videos related to

Sort By:
Pageof 27
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 4, 2018
Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapyChristine Chan, Thomas Schiano, Eliana Agudelo, et al.
Transplantation|January 26, 2018
Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in ChildrenEric M Przybyszewski, Elizabeth C Verna, Steven J Lobritto, et al.
Transplantation|September 12, 2014
Hepatitis C genotype influences post-liver transplant outcomesIsabel Campos-Varela, Jennifer C Lai, Elizabeth C Verna, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 25, 2012
Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort studyJennifer C Lai, Jacqueline G O'Leary, James F Trotter, et al.
Archives of Pathology & Laboratory Medicine|April 18, 2020
COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver TransplantationStephen M Lagana, Simona De Michele, Michael J Lee, et al.
Annals of Surgery|September 10, 2016
Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the StoryKarim J Halazun, Marc Najjar, Rita M Abdelmessih, et al.
Clinical and Translational Gastroenterology|April 3, 2019
Elbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT StudyIra M Jacobson, Fred Poordad, Roberto Firpi-Morell, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 20, 2020
Analysis of patients attitude to undergo urgent endoscopic procedures during COVID-19 outbreak in ItalyE Armellini, A Repici, C Alvisi, et al.
Digestive Diseases and Sciences|July 22, 2021
Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with CirrhosisGiuseppe Cullaro, Jessica B Rubin, Brett E Fortune, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 17, 2012
Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody-positive donorsMatthew S Chang, Sonja K Olsen, Elsa M Pichardo, et al.
Pageof 27